Cargando…

Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease

Systemic sclerosis (SSc) and mixed connective tissue disease (MCTD) are 2 conditions in which pulmonary hypertension (PH) can develop. We retrospectively analyzed the probability of PH in case of 83 patients (69 SSc and 14 MCTD). The European Society of Cardiology/European Respiratory Society (ESC/E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niklas, Karolina, Niklas, Arkadiusz, Mularek-Kubzdela, Tatiana, Puszczewicz, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076033/ https://www.ncbi.nlm.nih.gov/pubmed/29995796 http://dx.doi.org/10.1097/MD.0000000000011437

Ejemplares similares

Relationship between changes observed in nailfold capillaroscopy and serological profile, lung fibrosis, and elevated risk of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease
por: Niklas, Karolina, et al.
Publicado: (2022)

Multicentric reticulohistiocytosis in the course of undifferentiated connective tissue disease
por: Niklas, Karolina, et al.
Publicado: (2019)

Autoantibodies and Clinical Correlations in Polish Systemic Sclerosis Patients: A Cross-Sectional Study
por: Żebryk, Paweł, et al.
Publicado: (2023)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases
por: Smukowska-Gorynia, Anna, et al.
Publicado: (2023)

Rheumatic diseases induced by drugs and environmental factors: the state-of-the-art – part one
por: Niklas, Karolina, et al.
Publicado: (2016)

Rheumatic diseases induced by drugs and environmental factors: the state-of-the-art – part two
por: Niklas, Karolina, et al.
Publicado: (2016)

Optical coherence tomography improves the results of balloon pulmonary angioplasty in inoperable chronic thrombo-embolic pulmonary hypertension
por: Araszkiewicz, Aleksander, et al.
Publicado: (2017)

Genetic Background of Hypertension in Connective Tissue Diseases
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2020)

Prognostic Value of Pulmonary Artery Pulsatility Index in Right Ventricle Failure-Related Mortality in Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Sławek-Szmyt, Sylwia, et al.
Publicado: (2022)

Association of Electrocardiographic Signs of Right Ventricular Hypertrophy and Clot Localization in Chronic Thromboembolic Pulmonary Hypertension
por: Sławek-Szmyt, Sylwia, et al.
Publicado: (2022)

Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2021)

Chemerin, Resistin, and Adiponectin in Patients with Connective Tissue Diseases
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018)

Right heart catheterization procedures in patients with suspicion of pulmonary hypertension – experiences of a tertiary center
por: Grymuza, Maciej, et al.
Publicado: (2017)

Prognostic Value of Oxidative Stress Markers in Patients with Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertension
por: Smukowska-Gorynia, Anna, et al.
Publicado: (2019)

Oxidative Damage and Antioxidative Therapy in Systemic Sclerosis
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2014)

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
por: Kurzyna, Marcin, et al.
Publicado: (2017)

Rapid clinical and haemodynamic improvement in a patient with intermediate-high risk pulmonary embolism treated with transcatheter aspiration thrombectomy
por: Araszkiewicz, Aleksander, et al.
Publicado: (2019)

The concentration of tumor necrosis factor in the blood serum and in the urine and selected early organ damages in patients with primary systemic arterial hypertension
por: Puszkarska, Anna, et al.
Publicado: (2019)

Significance of antiplatelet therapy in emergency myocardial infarction treatment
por: Komosa, Anna, et al.
Publicado: (2014)

Continuous Aspiration Thrombectomy in High- and Intermediate-High-Risk Pulmonary Embolism in Real-World Clinical Practice
por: Araszkiewicz, Aleksander, et al.
Publicado: (2020)

Long term follow-up of children with juvenile systemic sclerosis, mixed connective tissue disease and pulmonary disease
por: Dracou, C, et al.
Publicado: (2008)

PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018)

Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative
por: Araszkiewicz, Aleksander, et al.
Publicado: (2020)

Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients
por: Cavagna, Lorenzo, et al.
Publicado: (2016)

Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs)
por: Bellan, Mattia, et al.
Publicado: (2021)

Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide
por: Sugawara, Eri, et al.
Publicado: (2017)

Association of red cell distribution width with pulmonary arterial hypertension in patients with mixed connective tissue disease
por: Jin, Yansheng, et al.
Publicado: (2023)

Connective tissue disease-associated pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2015)

Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature
por: Yang, Xiaoqin, et al.
Publicado: (2013)

Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team
por: Siennicka, Anna, et al.
Publicado: (2019)

Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype
por: El Kamouni, Hajar, et al.
Publicado: (2023)

Pulmonary hypertension in connective tissue diseases, new evidence and challenges
por: Vonk, Madelon C., et al.
Publicado: (2020)

Multifactorial Pulmonary Hypertension in Systemic Sclerosis
por: Hussain, Habiba, et al.
Publicado: (2020)

Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)
por: Kopeć, Grzegorz, et al.
Publicado: (2020)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases
por: Boueiz, Adel, et al.
Publicado: (2014)

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
por: Grünig, Ekkehard, et al.
Publicado: (2012)

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
por: Gaine, Sean, et al.
Publicado: (2017)

Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Moccaldi, Beatrice, et al.
Publicado: (2023)

The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease
por: Xiong, Jiangbiao, et al.
Publicado: (2022)

The importance of homocysteine in the development of cardiovascular complications in patients with rheumatoid arthritis
por: Głuszek, Jerzy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v28lf4tgb3ti4s6mm6gb9nm1m1